Skip to main content
Jen Bergeron, MD, Nephrology, Morgantown, WV

JenBergeronMD

Nephrology Morgantown, WV

Associate Program Director of Nephrology Fellowship. Assistant Professor of Medicine, Division of Nephrology

Dr. Bergeron is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bergeron's full profile

Already have an account?

  • Office

    Dept of Med, Div of Neph
    4th Floor HSCN, Rm 4076A
    Morgantown, WV 26506
    Phone+1 304-293-2551
    Fax+1 304-293-7373

Summary

  • Specializing in kidney physiology, cardiorenal syndrome, and palliative nephrology

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Nephrology, 2021 - 2023
  • University of Vermont Medical Center
    University of Vermont Medical CenterResidency, Internal Medicine, 2018 - 2021
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 2018

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2023 - 2026
  • WV State Medical License
    WV State Medical License 2023 - 2026
  • TN State Medical License
    TN State Medical License 2021 - 2023
  • VT State Medical License
    VT State Medical License 2018 - 2021
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Chief Fellow Vanderbilt, 2023

Publications & Presentations

Journal Articles

  • Perspectives of Polypharmacy and Its Effects on Quality of Life by Patients on Dialysis  
    Bergeron, Jennifer, Kidney News, 3/1/2024
  • Culture negative endocarditis with Tropheryma whipplei  
    Bergeron, J., Barrett, T., Repp, A., Annals of Internal medicine: Clinical Cases, 7/5/2022
  • Transcript decay mediated by RNase III in Borrelia burgdorferi  
    Snow, S., Bergeron, J. ... Schlax, P., Biochem Biophys Res Commun, 8/23/2020
  • Join now to see all

Abstracts/Posters

  • Validity and Practice Patterns of Mortality Risk Prediction Tools in Dialysis Patients
    Bergeron, J., Damon, C., Meagher, S., and Cheung KL, ASN Kidney Week, Orlando Florida, 11/3/2022
  • The gut: A giant Nephron
    Bergeron, J., Fogo, A., and Lewis, J, ASN Kidney Week, Orlando, 11/3/2022
  • Testing for UTIs in Adults without Urinary Symptoms: A High Value Care Case Analysis
    Bergeron, et. al, University of Vermont Quality Improvement Symposium, Virtual due to Covid-19, 6/2021
  • Join now to see all

Authored Content

  • Heart Failure DevicesMarch 2023
  • SGLT2 Inhibitors - A Cardiac vs Renal PerspectiveOctober 2020

Research History

  • Validity and utility of mortality risk prediction tools in the Vermont dialysis population2019 - Present
  • Outcomes of Desensitization in Living Donor Kidney Transplant Recipients2022 - 2023
  • Predicting technique failure in peritoneal dialysis2022 - 2023
  • Caveolin 3 mutations and regulation of the insulin receptor in lipotoxic cardiomyopathy2015 - 2015
  • mRNA processing in the alpha and rpsO-pnp operon of Borrelia burgdorferi is mediated by RNase III2013 - 2014
  • mRNA degradation in Borrelia burgdorferi2013 - 2013
  • Characterization of neuromodulators in Helisoma trivolvis2012 - 2012
  • Translational Regulation in Diverse Prokaryotes2011 - 2011

Professional Memberships